ABBV ready for shortABBV seems ready for short, RSI already broken trend line.
Details are on chart.
2.48EUR
4.37 BEUR
49.21 BEUR
1.77 B
About ABBVIE INC. DL-,01
Sector
CEO
Richard A. Gonzalez
Headquarters
North Chicago
Website
Employees (FY)
50 K
Founded
2011
ISIN
US00287Y1091
FIGI
BBG003Q17NP7
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where 4AB is featured.
Frequently Asked Questions
The current price of 4AB is 153.28 EUR — it has decreased by 0.09% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange ABBVIE INC. DL-,01 stocks are traded under the ticker 4AB.
ABBVIE INC. DL-,01 is going to release the next earnings report on Apr 26, 2024. Keep track of upcoming events with our Earnings Calendar.
4AB stock is 0.09% volatile and has beta coefficient of 0.45. Check out the list of the most volatile stocks — is ABBVIE INC. DL-,01 there?
One year price forecast for ABBVIE INC. DL-,01 has a max estimate of 194.50 EUR and a min estimate of 151.28 EUR.
4AB earnings for the last quarter are 2.79 EUR per share, whereas the estimation was 2.71 EUR resulting in a 2.87% surprise. The estimated earnings for the next quarter are 2.53 EUR per share. See more details about ABBVIE INC. DL-,01 earnings.
ABBVIE INC. DL-,01 revenue for the last quarter amounts to 13.17 B EUR despite the estimated figure of 12.98 B EUR. In the next quarter revenue is expected to reach 12.71 B EUR.
Yes, you can track ABBVIE INC. DL-,01 financials in yearly and quarterly reports right on TradingView.
4AB stock has fallen by 0.93% compared to the previous week, the month change is a 6.82% fall, over the last year ABBVIE INC. DL-,01 has showed a 5.06% increase.
4AB net income for the last quarter is 734.77 M EUR, while the quarter before that showed 1.67 B EUR of net income which accounts for −56.04% change. Track more ABBVIE INC. DL-,01 financial stats to get the full picture.
Today ABBVIE INC. DL-,01 has the market capitalization of 273.95 B, it has decreased by 6.56% over the last week.
Yes, 4AB dividends are paid quarterly. The last dividend per share was 1.46 EUR. As of today, Dividend Yield (TTM)% is 3.64%. Tracking ABBVIE INC. DL-,01 dividends might help you take more informed decisions.
ABBVIE INC. DL-,01 dividend yield was 3.87% in 2023, and payout ratio reached 220.33%. The year before the numbers were 3.53% and 86.17% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, 4AB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade ABBVIE INC. DL-,01 stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 50.00 K employees. See our rating of the largest employees — is ABBVIE INC. DL-,01 on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So ABBVIE INC. DL-,01 technincal analysis shows the sell today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating ABBVIE INC. DL-,01 stock shows the buy signal. See more of ABBVIE INC. DL-,01 technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on ABBVIE INC. DL-,01 future price: according to them, 4AB price has a max estimate of 194.50 EUR and a min estimate of 151.28 EUR. Read a more detailed ABBVIE INC. DL-,01 forecast: see what analysts think of ABBVIE INC. DL-,01 and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. ABBVIE INC. DL-,01 EBITDA is 26.10 B EUR, and current EBITDA margin is 49.30%. See more stats in ABBVIE INC. DL-,01 financial statements.